表达鞭毛蛋白的病毒样颗粒在CD4缺陷小鼠中促进流感疫苗IgG类别转换及长效抗体保护
研究在野生型和CD4敲除小鼠中评估表达鞭毛蛋白的病毒样颗粒(FliC-VLP)作为独立组分对流感疫苗的佐剂效应。FliC-VLP在野生型和CD4敲除小鼠中均促进Th1偏向的IgG类别转换抗体、增强保护及长效IgG应答,而可溶性鞭毛蛋白的佐剂效应为Th2偏向且依赖CD4 T细胞。
要点
- FliC-VLP在野生型和CD4敲除小鼠中均促进Th1偏向IgG类别转换抗体、增强保护及长效IgG应答。
- 可溶性鞭毛蛋白佐剂效应为Th2偏向且依赖CD4 T辅助细胞。
- FliC-VLP佐剂效应较少依赖CD4 T细胞和鞭毛蛋白介导的先天免疫信号通路。
核心结论
- FliC-VLP在免疫健全及CD4 T细胞缺陷条件下均可能发挥有效佐剂作用。
研究设计与样本
- 在野生型和突变(CD4敲除)小鼠模型中研究FliC-VLP作为独立组分对流感疫苗接种的佐剂效应与机制。
主要发现
- FliC-VLP佐剂化流感疫苗在野生型和CD4敲除小鼠中均高效促进Th1偏向IgG类别转换抗体、增强保护及长效IgG抗体应答。
- 可溶性鞭毛蛋白佐剂效应为Th2偏向且需要CD4 T辅助细胞。
- FliC-VLP佐剂效应较少依赖CD4 T细胞和鞭毛蛋白介导的先天免疫信号通路。
临床怎么用
- FliC-VLP或可作为流感疫苗佐剂用于免疫健全及CD4 T细胞缺陷人群的疫苗增强策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Incorporation of membrane-anchored flagellin molecules into the surfaces of influenza virus-like particles (VLP) was previously reported to promote T helper (Th) 1-biased IgG antibody production and protective efficacy of co-presented vaccine antigens. Herein, we investigated the potential adjuvant effects and mechanisms of flagellin-expressing VLP (FliC-VLP) as an independent component on influenza vaccination in wild-type and mutant mouse models. FliC-VLP adjuvanted influenza vaccination was highly effective in promoting the induction of Th1-biased IgG isotype switched antibodies, enhanced protection, and long-lasting IgG antibody responses in both wild-type and CD4-knockout mice. In contrast, the adjuvant effects of soluble flagellin were Th2-biased and required CD4 T helper cells. The adjuvant effects of FliC-VLP were less dependent on CD4 T cells and flagellin-mediated innate immune signaling pathways. The results suggest that FliC-VLP might play an effective adjuvant role in an immune competent condition as well as in a defect of CD4 T cells.
引用
- Ko EJ, Lee Y, Lee YT, et al. Flagellin-expressing virus-like particles exhibit adjuvant effects on promoting IgG isotype-switched long-lasting antibody induction and protection of influenza vaccines in CD4-deficient mice. Vaccine. 2019. PMID: 31101421. doi:10.1016/j.vaccine.2019.05.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。